Deep Track Capital, LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $3.03 Billion distributed in 66 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spring Works Therapeutics, Inc. with a value of $171M, Amgen Inc with a value of $156M, Insmed Inc with a value of $130M, Dyne Therapeutics, Inc. with a value of $129M, and Alnylam Pharmaceuticals, Inc. with a value of $124M.

Examining the 13F form we can see an increase of $393M in the current position value, from $2.63B to 3.03B.

Deep Track Capital, LP is based out at Greenwich, CT

Below you can find more details about Deep Track Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $3.03 Billion
Healthcare: $3.02 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 66
  • Current Value $3.03 Billion
  • Prior Value $2.63 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 19 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 16 stocks
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.